title: Sensorineural hearing loss associated with systemic lupus erythematosus.
abstract: Because our recent clinical experiences suggested a possible association between hearing loss and systemic lupus erythematosus (SLE), we prospectively studied the hearing of 30 patients hospitalized because of exacerbation of SLE. Twenty-nine of the 30 patients were receiving immunosuppressive therapy at the time of testing. We found an 8% incidence of substantial, previously undetected hearing loss without attributable cause. Hearing loss could not be correlated to age, sex, disease activity, organ-system involvement, laboratory test abnormalities, or duration of symptoms of SLE. Otolaryngologists treating patients with unexplainable hearing loss--particularly if it is sudden, fluctuating, or rapidly progressive--are alerted to the possibility of underlying systemic autoimmunity. We advise physicians who frequently treat patients with SLE to include questions on hearing in the review of systems and to refer the patient with hearing complaints for thorough otologic evaluation.
authors.forename: C A
authors.initials: CA
authors.lastname: Bowman
authors.forename: F H
authors.initials: FH
authors.lastname: Linthicum
authors.forename: R A
authors.initials: RA
authors.lastname: Nelson
authors.forename: K
authors.initials: K
authors.lastname: Mikami
authors.forename: F
authors.initials: F
authors.lastname: Quismorio
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001299:Audiometry; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
chemical_list: D000305:Adrenal Cortex Hormones